October 01, 2015
Article
Aziz Nazha, Hematology and Medical Oncology Fellow, Cleveland Clinic, discusses adverse events associated with treatment for myelodysplastic syndrome (MDS).
Aziz Nazha, Hematology and Medical Oncology Fellow, Cleveland Clinic, discusses the future of treating patients with myelodysplastic syndrome (MDS).
How to Bring Peace and Normalcy to Children With Cancer
Updated Treatment Options Improve Advanced HR+ Breast Cancer Outcomes
Debunking Hospice Misconceptions: A Focus on End-of-Life Care
My Favorite Things in the Holiday Season